입원 환자의 후향적 전자의무기록 분석을 통한 수혈과 관련된 급성 이상 반응의 발생 빈도와 임상 양상
Frequency and clinical characteristics of adverse transfusion reactions in hospitalized patients: A retrospective review of electronic medical records
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Adverse transfusion reactions (ATRs) are unfavorable reactions to the transfused unit, and the severity may be different among individuals, depending upon the type of reactions and the patient’s susceptibility. It is necessary to operate and manage a systematic monitoring system to minimize these ATRs and increase the safety. This study was conducted to evaluate clinical features of transfusion-related adverse events and morbidities. Methods: We retrospectively analyzed transfusion data from electronic medical records during the recent 3 years (April 2017 to April 2020) at Seoul National University Bundang Hospital. The electronic search strategy was applied to search for the type of blood products prescribed and identify symptoms that occurred during transfusion as recorded in the nursing chart which is based on the International Classification for Nursing Practice. Results: A total of 18,772 people were transfused during the study period. A total of 524 people were reported as suspected ATRs, of whom 466 were finally confirmed. Red blood cell was the most frequent culprit blood product (59.9%), followed by apheresis platelet (25.1%), fresh frozen plasma (10.1%), and platelet (4.9%). Clinical symptoms included fever (54.9%), urticaria and itching (34.7%), chillness and shivering (21.9%), and chest discomfort (6.0%), dyspnea (5.3%), cold sweating (3.8%), hypotension (2.1%), and palpitations (1.9%). The severity of ATRs were mild (91.8%), moderate (7.1%), and severe (1.1%). Conclusion: ATRs are mostly mild, but life-threatening reactions may occur. Physicians should be aware of various features of ATRs to appropriately recognize and treat such patients.
Abstract
Purpose: Adverse transfusion reactions (ATRs) are unfavorable reactions to the transfused unit, and the severity may be different among individuals, depending upon the type of reactions and the patient’s susceptibility. It is necessary to operate and manage a systematic monitoring system to minimize these ATRs and increase the safety. This study was conducted to evaluate clinical features of transfusion-related adverse events and morbidities. Methods: We retrospectively analyzed transfusion data from electronic medical records during the recent 3 years (April 2017 to April 2020) at Seoul National University Bundang Hospital. The electronic search strategy was applied to search for the type of blood products prescribed and identify symptoms that occurred during transfusion as recorded in the nursing chart which is based on the International Classification for Nursing Practice. Results: A total of 18,772 people were transfused during the study period. A total of 524 people were reported as suspected ATRs, of whom 466 were finally confirmed. Red blood cell was the most frequent culprit blood product (59.9%), followed by apheresis platelet (25.1%), fresh frozen plasma (10.1%), and platelet (4.9%). Clinical symptoms included fever (54.9%), urticaria and itching (34.7%), chillness and shivering (21.9%), and chest discomfort (6.0%), dyspnea (5.3%), cold sweating (3.8%), hypotension (2.1%), and palpitations (1.9%). The severity of ATRs were mild (91.8%), moderate (7.1%), and severe (1.1%). Conclusion: ATRs are mostly mild, but life-threatening reactions may occur. Physicians should be aware of various features of ATRs to appropriately recognize and treat such patients.
참고문헌 (25)
- Osterman JL, "Blood product transfusions and reactions", Hematol Oncol Clin North Am, 31, pp.1159~1170 (2017)
- Garraud O, "Transfusion-associated hazards : a revisit of their presentation", Transfus Clin Biol, 25, pp.118~135 (2018)
- Hendrickson JE, "Noninfectious serious hazards of transfusion", Anesth Analg, 108, pp.759~769 (2009)
- Bolton-Maggs PH, "Serious Hazards of Transfusion(SHOT)haemovigilance and progress is improving transfusion safety", Br J Haematol, 163, pp.303~314 (2013)
- Faber JC, "Worldwide overview of existing haemovigilance systems", Transfus Apher Sci, 31, pp.99~110 (2004)
- de Vries RR, "Haemovigilance: an effective tool for improving transfusion practice", Vox Sang, 100, pp.60~67 (2011)
- 조주영, "Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea", Annals of Laboratory Medicine, 36(1), pp.36~41 (2016), 대한진단검사의학회
- Negi G, "Blood transfusion safety : a study of adverse reactions at the blood bank of a tertiary care center", Adv Biomed Res, 4, pp.237~ (2015)
- Kim MH, "Surveillance of contrast-media-induced hypersensitivity reactions using signals from an electronic medical recording system", Ann Allergy Asthma Immunol, 108, pp.167~171 (2012)
- Tinegate H, "Prepared by the BCSH Blood Transfusion Task Force", Br J Haematol, 159, pp.143~153 (2012)
- "Hemovigilance reference information" (2020)[URL]
- Kato H, "A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history", Vox Sang, 108, pp.243~250 (2015)
- Domen RE, "Allergic transfusion reactions : an evaluation of 273 consecutive reactions", Arch Pathol Lab Med, 127, pp.316~320 (2003)
- Savage WJ, "Transfusion reactions", Hematol Oncol Clin North Am, 30, pp.619~634 (2016)
- Harvey AR, "Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012", Transfusion, 55, pp.709~718 (2015)
- AuBuchon JP, "AABB validation study of the CDC's National Healthcare Safety Network Hemovigilance Module adverse events definitions protocol", Transfusion, 54, pp.2077~2083 (2014)
- Pandey S, "Adverse effects of plasma transfusion", Transfusion, 52(Suppl 1), pp.65S~79S (2012)
- Roubinian N, "TACO and TRALI : biology, risk factors, and prevention strategies", Hematology Am Soc Hematol Educ Program, 2018, pp.585~594 (2018)
- Dunbar NM, "Transfusion reaction reporting in the era of hemovigilance : where form meets function", Transfusion, 51, pp.2583~2587 (2011)
- Brecher ME, "Technical manual", pp.633~665 (2005), American Association of Blood Banks
- Martí-Carvajal AJ, "Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions", Cochrane Database Syst Rev, 2010, pp.CD007539~ (2010)
- DeLisle J, "Is this a blood transfusion reaction? Don't hesitate; check it out", J Infus Nurs, 41, pp.43~51 (2018)
- Murphy MF, "Transfusion practice and safety : current status and possibilities for improvement", Vox Sang, 100, pp.46~59 (2011)
- Heddle NM, "Challenges and opportunities to prevent transfusion errors : a Qualitative Evaluation for Safer Transfusion(QUEST)", Transfusion, 52, pp.1687~1695 (2012)
- Vossoughi S, "Safety incident reports associated with blood transfusions", Transfusion, 59, pp.2827~2832 (2019)